Dogwood Therapeutics (DWTX) Goodwill & Intangibles (2024 - 2026)

Dogwood Therapeutics (DWTX) has reported Goodwill & Intangibles for 3 consecutive years, with $80.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Goodwill & Intangibles rose 3.14% year-over-year to $80.0 million; the TTM figure through Mar 2026 stood at $80.0 million (up 3.14% YoY), while the FY2025 annual figure was $81.4 million, up 4.98% from the prior year.
• Goodwill & Intangibles declined to $80.0 million in Q1 2026 per DWTX's latest filing, from $81.4 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $81.8 million in Q2 2025 and bottomed at $77.5 million in Q4 2024.
• Historically, Goodwill & Intangibles has averaged $79.7 million across 3 years, with a median of $80.1 million in 2025.
• Annual changes were most pronounced in 2025 — Goodwill & Intangibles gained 4.98% — and 2026, when it grew 3.14%.
• Dogwood Therapeutics' Goodwill & Intangibles stood at $77.5 million in 2024, then grew by 4.98% to $81.4 million in 2025, then declined by 1.67% to $80.0 million in 2026.
• Business Quant data shows DWTX's Goodwill & Intangibles at $80.0 million in Q1 2026, $81.4 million in Q4 2025, and $80.1 million in Q3 2025.